Advertisement
CCR Translations

New Drug for Chronic Myeloid Leukemia Might Stimulate the Market

Martin C. Müller
DOI: 10.1158/1078-0432.CCR-20-3684 Published January 2021

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: October 2020 to January 2021

AbstractFull-text HTMLPDF
Total434577109

Cited By

Article Information

Volume 27, Issue 1, pp. 3-4

DOI 
https://doi.org/10.1158/1078-0432.CCR-20-3684
PubMed 
33109738
Published By 
American Association for Cancer Research
Print ISSN 
1078-0432
Online ISSN 
1557-3265
History 
  • Received October 2, 2020
  • Revision received October 10, 2020
  • Accepted October 23, 2020
  • Published first October 27, 2020.

Article Versions

Copyright & Usage 
©2020 American Association for Cancer Research.

Author Information

  1. Martin C. Müller*
  1. Institute for Hematology and Oncology (IHO GmbH), Mannheim, Germany.
  1. ↵*Corresponding Author:
    Martin C. Müller, Institute for Hematology and Oncology (IHO GmbH), Hans-Boeckler-Str. 1-3, Mannheim 68161, Germany. Phone: 49-621-44591622; Fax: 49-621-9500009; E-mail: martin.mueller{at}i-ho.com
View Full Text
Back to top
View this article with LENS

Open full page PDF
Article Alerts
Email Article
Citation Tools
New Drug for Chronic Myeloid Leukemia Might Stimulate the Market
Martin C. Müller
Clin Cancer Res January 1 2021 (27) (1) 3-4; DOI: 10.1158/1078-0432.CCR-20-3684
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Jump to section

Advertisement